Ellis P Ron

Endocyte, Inc.

Avg. Two Year Performance

66% Avg. Purchase Return 29% Compound

58% Avg. Sale Return 26% Compound

Holdings: 320.04K shares

Last Three Months: 05-Feb-24 -- 04-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Major

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions